Immediate Treatment for Stroke
For acute ischemic stroke, intravenous alteplase (rtPA) 0.9 mg/kg (maximum 90 mg) is the priority treatment if the patient can be treated within 3 hours of symptom onset and meets eligibility criteria; if thrombolysis is not given or contraindicated, aspirin 160-300 mg should be started within 24-48 hours after excluding hemorrhage. 1
Initial Emergency Management
Immediate Assessment and Stabilization
- Treat stroke as a life-threatening emergency requiring immediate evaluation and treatment 1
- Protect airway, breathing, and circulation (ABCs), especially in seriously ill or comatose patients 1
- Manage elevated blood pressure cautiously—do not lower aggressively unless severely elevated 1
- Obtain urgent brain imaging (CT or MRI) to exclude hemorrhagic stroke before any antithrombotic therapy 1
Time-Critical Thrombolytic Therapy
Intravenous rtPA (Alteplase):
- Strongly recommended for carefully selected patients within 3 hours of symptom onset 1
- Dose: 0.9 mg/kg (maximum 90 mg) administered intravenously 1
- Requires strict adherence to NINDS selection criteria 1
- Do NOT substitute streptokinase or other thrombolytic agents for rtPA—they are not safe alternatives 1
Critical Caveat: Safe use of rtPA demands close observation and careful ancillary care; improper patient selection significantly increases hemorrhagic complications 1
Mechanical Thrombectomy
- Mechanical thrombectomy with stent retrievers is recommended for large vessel occlusions (ICA or proximal MCA) when treatment can be initiated within 6 hours 1
- Blood pressure should be maintained ≤180/105 mm Hg during and for 24 hours after the procedure 1
- Stent retrievers are preferred over older devices like MERCI 1
Antiplatelet Therapy
Aspirin Administration:
- Give aspirin 160-300 mg within 24-48 hours of stroke onset 1, 2
- Prevents approximately 5-10 deaths and recurrent strokes per 1000 patients treated 3, 4
- If rtPA was given, delay aspirin for 24 hours 1
- Can be administered orally, rectally, or via nasogastric tube if swallowing is unsafe 4
- Small increase in hemorrhagic risk (approximately 2 per 1000) is outweighed by benefits 5
Important: Aspirin is NOT a substitute for thrombolytic therapy in eligible patients 1
Anticoagulation—NOT Recommended Acutely
- Urgent anticoagulation (heparin, low-molecular-weight heparin, heparinoids) is NOT recommended for routine acute stroke treatment 1
- Does not reduce early recurrent stroke or improve outcomes 1
- Significantly increases risk of symptomatic hemorrhagic transformation, especially in moderate-to-severe strokes 1
- Do not initiate anticoagulation within 24 hours of rtPA administration 1
Supportive Care and Monitoring
Temperature Management
- Monitor temperature every 4 hours for first 48 hours 1
- For temperature >37.5°C, investigate infection and initiate antipyretics 1
Early Mobilization
- Begin rehabilitation assessment within 48 hours 1
- Frequent, brief out-of-bed activity (sitting, standing, walking) within 24 hours if no contraindications 1
Seizure Management
- Do NOT give prophylactic anticonvulsants to patients without seizures 1
- Treat acute seizures with short-acting medications (e.g., lorazepam IV) 1
- Single self-limiting seizure at onset does not require long-term anticonvulsant therapy 1
Cerebral Edema Management
- Corticosteroids are NOT recommended for cerebral edema 1
- Osmotherapy and hyperventilation for deteriorating patients with increased intracranial pressure 1
- Surgical decompression for large cerebellar infarctions causing brainstem compression 1